Page 133 - Read Online
P. 133

Page 12 of 12                                                    Cao et al. J Transl Genet Genom 2019;3:4. I  https://doi.org/10.20517/jtgg.2018.16

               78.  Iyengar SK, Sedor JR, Freedman BI, Kao WH, Kretzler M, et al. Genome-wide association and trans-ethnic meta-analysis for advanced
                   diabetic kidney disease: family investigation of nephropathy and diabetes (FIND). PLoS Genet 2015;11:e1005352.
               79.  Li Q, Li C, Li H, Zeng L, Kang Z, et al. Effect of AMP-activated protein kinase subunit alpha 2 (PRKAA2) genetic polymorphisms on
                   susceptibility to type 2 diabetes mellitus and diabetic nephropathy in a Chinese population. J Diabetes 2018;10:43-9.
               80.  Limou S, Vince N, Parsa A. Lessons from CKD-related genetic association studies-moving forward. Clin J Am Soc Nephrol 2018;13:140-52.
               81.  Joyner MJ, Paneth N. Seven questions for personalized medicine. JAMA 2015;314:999-1000.
               82.  Witasp A, Nordfors L, Carrero JJ, Luttropp K, Lindholm B, et al. Genetic studies in chronic kidney disease: interpretation and clinical
                   applicability. J Nephrol 2012;25:851-64.
               83.  Zheng M, Lv LL, Ni J, Ni HF, Li Q, et al. Urinary podocyte-associated mRNA profile in various stages of diabetic nephropathy. PLoS One
                   2011;6:e20431.
               84.  Cao YH, Lv LL, Zhang X, Hu H, Ding LH, et al. Urinary vimentin mRNA as a potential novel biomarker of renal fibrosis. Am J Physiol
                   Renal Physiol 2015;309:F514-22.
               85.  Zhou LT, Cao YH, Lv LL, Ma KL, Chen PS, et al. Feature selection and classification of urinary mRNA microarray data by iterative random
                   forest to diagnose renal fibrosis: a two-stage study. Sci Rep 2017;7:39832.
               86.  Breit M, Weinberger KM. Metabolic biomarkers for chronic kidney disease. Arch Biochem Biophys 2016;589:62-80.
               87.  Hocher B, Adamski J. Metabolomics for clinical use and research in chronic kidney disease. Nat Rev Nephrol 2017;13:269-84.
               88.  Lyu LL, Feng Y, Liu BC. Urinary biomarkers for chronic kidney disease with a focus on gene transcript. Chin Med J (Engl) 2017;130:2251-6.
               89.  Chen R, Mias GI, Li-Pook-Than J, Jiang L, Lam HY, et al. Personal omics profiling reveals dynamic molecular and medical phenotypes.
                   Cell 2012;148:1293-307.
   128   129   130   131   132   133   134   135   136   137   138